v3.26.1
Condensed Balance Sheets (Unaudited) (Parentheticals) - USD ($)
Jun. 30, 2026
Jan. 30, 2026
Jan. 29, 2026
Dec. 31, 2025
Preference shares, par value $ 0.0001     $ 0.0001
Preference shares, authorized 5,000,000     5,000,000
Preference shares, issued    
Preference shares, outstanding    
Founder shares are no longer subject to forfeiture     5,914,286  
Founder Shares        
Number of additional shares issued     985,715  
Sponsor | Over-Allotment Option        
Founder shares are no longer subject to forfeiture   771,429    
Class A Ordinary Shares        
Ordinary shares, par value $ 0.0001     $ 0.0001
Ordinary shares, authorized 485,000,000     485,000,000
Ordinary shares, issued 326,875    
Ordinary shares, outstanding 326,875    
Subject to possible redemption $ 13,800,000    
Redemption value price per share $ 10.15     $ 0
Subject to possible redemption price per share 0.0001     0.0001
Class B Ordinary Shares        
Ordinary shares, par value [1],[2] $ 0.0001     $ 0.0001
Ordinary shares, authorized [1],[2] 10,000,000     10,000,000
Ordinary shares, issued [1],[2] 5,914,286     5,914,286
Ordinary shares, outstanding [1],[2] 5,914,286     5,914,286
Class B Ordinary Shares | Over-Allotment Option        
Class B ordinary shares subject to forfeiture 771,429      
[1] Includes an aggregate of 771,429 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On January 30, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option, 771,429 Founder Shares are no longer subject to forfeiture by the Sponsor (Note 5).
[2] On January 29, 2026, the Company issued an additional 985,715 Founder Shares to the Sponsor through a share capitalization, resulting in the Sponsor holding an aggregate of 5,914,286 Founder Shares. All share and per share data have been retrospectively presented (Note 5).